221 filings
Page 3 of 12
8-K
ODYY
Odyssey Health, Inc.
6 Jan 23
Departure of Directors or Certain Officers
5:10pm
8-K
ODYY
Odyssey Health, Inc.
3 Jan 23
Entry into a Material Definitive Agreement
8:00am
10-Q
2023 Q1
ODYY
Odyssey Health, Inc.
Quarterly report
14 Dec 22
5:10pm
DEF 14A
ODYY
Odyssey Health, Inc.
Definitive proxy
29 Nov 22
5:05pm
8-K
ODYY
Odyssey Health, Inc.
25 Nov 22
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
8:30am
8-K
ODYY
Odyssey Health, Inc.
23 Nov 22
Other Events
5:15pm
8-K
ODYY
Odyssey Health, Inc.
23 Nov 22
Entry into a Material Definitive Agreement
5:10pm
4
Gregory W Gironda
23 Nov 22
Odyssey Health / Gregory W Gironda ownership change
4:04pm
3
ODYY
Odyssey Health, Inc.
23 Nov 22
Odyssey Health / Gregory W Gironda ownership change
4:03pm
4
Erik Emerson
23 Nov 22
Odyssey Health / Erik C. Emerson ownership change
4:02pm
3
Erik Emerson
23 Nov 22
Odyssey Health / Erik C. Emerson ownership change
4:01pm
PRE 14A
ODYY
Odyssey Health, Inc.
Preliminary proxy
18 Nov 22
5:00pm
8-K
ODYY
Odyssey Health, Inc.
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
ODYY
Odyssey Health, Inc.
1 Nov 22
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
8:45am
10-K
2022 FY
ODYY
Odyssey Health, Inc.
Annual report
31 Oct 22
5:04pm
4
Jacob PH.D Vanlandingham
19 Oct 22
Odyssey Health / JACOB PH.D VANLANDINGHAM ownership change
9:27pm
4
ODYY
Odyssey Health, Inc.
19 Oct 22
Odyssey Health / CHRISTINE FARRELL ownership change
9:21pm
8-K
ODYY
Odyssey Health, Inc.
3 Oct 22
Entry into a Material Definitive Agreement
4:36pm
8-K
ODYY
Odyssey Health, Inc.
30 Sep 22
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
5:51pm
8-K
ODYY
Odyssey Health, Inc.
30 Sep 22
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
5:20pm